Personen

TOP 5 Publikationen:

1. Mertens L, Koslowski M, Betzler F, Brand M, Evens R, Kärtner L, Jungaberle A, Jungaberle H, Majic T, Schmitz C, Ströhle A, Scharf D, Spangemacher M, Wolff M, Assadi Z, Bahri S, Becher L, Färber LV, Kirchen N, Kulakova E, Kunz L, Meijer A, Rohrmoser B, Wellek S, Berger M, Gründer G. Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.JAMA Psychiatry. 2026 83(5):448-460. Epub 2026 Mar 18.
2. Hart XM, Hirjak D, Eap CB, Eichentopf L, Fritze S, Lense XM, Scharf D, Schilling C, Schwind N, Post P, Wesner K, Gründer G. High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic Setting.Pharmacopsychiatry. 2026 May 20. [Epub ahead of print].
3. Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens L. [Are psychedelics fast acting antidepressant agents?]Nervenarzt. 2022 93(3):254-262. Epub 2022 Feb 1.